drugset / Trial / NCT00938613
Compare CE-Budesonide Nasal Solution & Rhinocort Aqua in an EEC Study of AR
RandomizedCrossoverTriple-blindTreatment
Summary
The primary objective of this study was to compare the relative efficacy of Budesonide administered via Captisol-Enabled Budesonide nasal solution and Rhinocort Aqua in patients with seasonal allergic rhinitis (SAR) exposed to controlled ragweed pollen using an EEC model.
Timeline
- Start
- 2007-02
- Primary completion
- 2007-04
- Completion
- 2007-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Budesonide | Small molecule | 32 ug | Intranasal |